10x Genomics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

BST:1KJ Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
22 Nov 24	Sell€76,465	Benjamin Hindson	Individual	5,807	€13.17
22 Nov 24	Sell€88,131	Serge Saxonov	Individual	6,693	€13.17
22 Aug 24	Sell€60,059	Justin McAnear	Individual	2,961	€20.28
22 Aug 24	Sell€88,253	Benjamin Hindson	Individual	4,351	€20.28
22 Aug 24	Sell€136,893	Serge Saxonov	Individual	6,749	€20.28
22 May 24	Sell€109,390	Serge Saxonov	Individual	4,877	€22.43
22 May 24	Sell€65,854	Justin McAnear	Individual	2,936	€22.43
22 May 24	Sell€91,671	Benjamin Hindson	Individual	4,087	€22.43
04 Mar 24	Sell€188,763	Serge Saxonov	Individual	4,660	€40.51
22 Feb 24	Sell€79,906	Justin McAnear	Individual	1,865	€42.85
22 Feb 24	Sell€120,867	Serge Saxonov	Individual	2,821	€42.85
22 Feb 24	Sell€111,955	Benjamin Hindson	Individual	2,613	€42.85

Insider Trading Volume

Insider Buying: 1KJ insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of 1KJ?
Owner Type	Number of Shares	Ownership Percentage
State or Government	45,475	0.0376%
General Public	3,942,817	3.26%
Individual Insiders	10,131,842	8.37%
Institutions	106,934,314	88.3%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 2.4%.

Top Shareholders

Top 25 shareholders own 79.76% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
15.1%	FMR LLC	18,238,630	€257.2m	2%	0.01%
9.06%	The Vanguard Group, Inc.	10,972,930	€154.7m	7.69%	no data
8.88%	ARK Investment Management LLC	10,750,345	€151.6m	15.4%	1.06%
5.63%	BlackRock, Inc.	6,815,370	€96.1m	6.61%	no data
5.26%	Nikko Asset Management Co., Ltd.	6,373,212	€89.9m	3.75%	0.03%
3.86%	T. Rowe Price Group, Inc.	4,677,678	€66.0m	-7.13%	0.01%
3.6%	Morgan Stanley Investment Management Inc.	4,353,634	€61.4m	10.5%	0.05%
3.33%	Serge Saxonov	4,028,605	€56.8m	0.08%	no data
3.13%	VR Adviser, LLC	3,790,422	€53.4m	0%	2.68%
2.67%	Benjamin Hindson	3,237,278	€45.6m	-0.03%	no data
2.3%	Citadel Advisors LLC	2,779,970	€39.2m	731%	0.04%
2.02%	John Stuelpnagel	2,441,337	€34.4m	0%	no data
1.81%	Brown Capital Management, LLC	2,195,319	€31.0m	-11.6%	0.41%
1.79%	UBS Asset Management AG	2,167,739	€30.6m	4.32%	no data
1.5%	Geode Capital Management, LLC	1,815,710	€25.6m	2.41%	no data
1.45%	State Street Global Advisors, Inc.	1,750,643	€24.7m	7.13%	no data
1.25%	Deerfield Management Company, L.P. Series C	1,508,943	€21.3m	153%	0.37%
1.21%	Point72 Asset Management, L.P.	1,466,227	€20.7m	0%	0.05%
1.17%	Voloridge Investment Management, LLC	1,414,804	€19.9m	-1.75%	0.07%
1.08%	Morgan Stanley, Investment Banking and Brokerage Investments	1,310,779	€18.5m	27.6%	no data
0.82%	Norges Bank Investment Management	991,051	€14.0m	0%	no data
0.79%	Soleus Capital Management, L.P.	951,000	€13.4m	32.3%	1.02%
0.76%	Millennium Management LLC	918,757	€13.0m	-32.5%	0.01%
0.67%	Eaton Vance Management	811,894	€11.4m	0.79%	no data
0.66%	Capital Research and Management Company	793,300	€11.2m	0%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/25 04:19
End of Day Share Price	2024/12/20 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

10x Genomics, Inc. is covered by 23 analysts. 16 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Ishan Majumdar	Baptista Research
Luke Sergott	Barclays
Michael Ryskin	BofA Global Research